Cargando…
Sulodexide pretreatment attenuates renal ischemia-reperfusion injury in rats
Sulodexide is a potent antithrombin agent, however, whether it has beneficial effects on renal ischemia-reperfusion injury (IRI) remains unknown. In the present study, we assessed the therapeutic effects of sulodexide in renal IRI and tried to investigate the potential mechanism. One dose of sulodex...
Autores principales: | Yin, Jianyong, Chen, Weibin, Ma, Fenfen, Lu, Zeyuan, Wu, Rui, Zhang, Guangyuan, Wang, Niansong, Wang, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354786/ https://www.ncbi.nlm.nih.gov/pubmed/28036282 http://dx.doi.org/10.18632/oncotarget.14309 |
Ejemplares similares
-
Protective Role of Sulodexide on Renal Injury Induced by Limb Ischemia-Reperfusion
por: Yuan, Tao, et al.
Publicado: (2021) -
Renalase attenuates hypertension, renal injury and cardiac remodelling in rats with subtotal nephrectomy
por: Yin, Jianyong, et al.
Publicado: (2016) -
Antithrombin III/SerpinC1 insufficiency exacerbates renal ischemia/reperfusion injury
por: Wang, Feng, et al.
Publicado: (2015) -
Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic‐reperfusion injury
por: Yin, Jianyong, et al.
Publicado: (2017) -
Pretreatment of parecoxib attenuates hepatic ischemia/reperfusion injury in rats
por: Zhang, Tao, et al.
Publicado: (2015)